These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6268703)

  • 1. Inheritance of delta 9-tetrahydrocannabinol seizure susceptibility in rabbits.
    Fish BS; Consroe P; Fox RR
    J Hered; 1981; 72(3):215-6. PubMed ID: 6268703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ontogeny of delta-9-tetrahydrocannabinol responsiveness in the rabbit.
    Fish BS; Consroe P
    Dev Psychobiol; 1983 Mar; 16(2):147-58. PubMed ID: 6299864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabbit behavioral model of marijuana psychoactivity in humans.
    Consroe P; Fish BS
    Med Hypotheses; 1981 Aug; 7(8):1079-90. PubMed ID: 6270517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid induced behavioral convulsions in rabbits.
    Martin P; Consroe P
    Science; 1976 Nov; 194(4268):965-7. PubMed ID: 982057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.
    Tanda G; Munzar P; Goldberg SR
    Nat Neurosci; 2000 Nov; 3(11):1073-4. PubMed ID: 11036260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convulsant-anticonvulsant properties of delta-9-tetrahydrocannabinol in rabbits.
    Fish BS; Consroe P; Fox RR
    Behav Genet; 1983 Mar; 13(2):205-11. PubMed ID: 6305325
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerance to, and symmetrical cross-tolerance between, cannabinol and delta 9-tetrahydrocannabinol.
    Fish BS; Consroe P
    Experientia; 1981 Mar; 37(3):295-6. PubMed ID: 6263678
    [No Abstract]   [Full Text] [Related]  

  • 8. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
    Katsidoni V; Kastellakis A; Panagis G
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents.
    Manwell LA; Charchoglyan A; Brewer D; Matthews BA; Heipel H; Mallet PE
    J Pharmacol Toxicol Methods; 2014; 70(1):120-7. PubMed ID: 24973534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced type III neuregulin 1 expression does not modulate the behavioural sensitivity of mice to acute Δ
    Lloyd D; Talmage D; Shannon Weickert C; Karl T
    Pharmacol Biochem Behav; 2018 Jul; 170():64-70. PubMed ID: 29750976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
    Takeda S; Jiang R; Aramaki H; Imoto M; Toda A; Eyanagi R; Amamoto T; Yamamoto I; Watanabe K
    J Pharm Sci; 2011 Mar; 100(3):1206-11. PubMed ID: 20891010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys.
    Justinova Z; Tanda G; Munzar P; Goldberg SR
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):186-94. PubMed ID: 14668977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant drug antagonism of delta9tetrahydrocannabinol-induced seizures in rabbits.
    Consroe P; Martin P; Eisenstein D
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):1-13. PubMed ID: 841172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.
    Kangas BD; Leonard MZ; Shukla VG; Alapafuja SO; Nikas SP; Makriyannis A; Bergman J
    J Pharmacol Exp Ther; 2016 Apr; 357(1):125-33. PubMed ID: 26826191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological effects of acute and repeated administration of Delta(9)-tetrahydrocannabinol in adolescent and adult rats.
    Wiley JL; O'connell MM; Tokarz ME; Wright MJ
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1097-105. PubMed ID: 17172531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of delta9-tetrahydrocannabinol with other pharmacological agents.
    Consroe P; Jones B; Laird H
    Ann N Y Acad Sci; 1976; 281():198-211. PubMed ID: 798523
    [No Abstract]   [Full Text] [Related]  

  • 17. Δ-Tetrahydrocannabinol induces cytotoxicity in macrophage J774-1 cells: involvement of cannabinoid receptor 2 and p38 MAPK.
    Yamaori S; Ishii H; Chiba K; Yamamoto I; Watanabe K
    Toxicology; 2013 Dec; 314(2-3):254-61. PubMed ID: 24184660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in mice.
    Senn R; Keren O; Hefetz A; Sarne Y
    Pharmacol Biochem Behav; 2008 Jan; 88(3):230-7. PubMed ID: 17888506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marijuana poisoning.
    Fitzgerald KT; Bronstein AC; Newquist KL
    Top Companion Anim Med; 2013 Feb; 28(1):8-12. PubMed ID: 23796481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance.
    Müller-Vahl KR; Prevedel H; Theloe K; Kolbe H; Emrich HM; Schneider U
    Neuropsychopharmacology; 2003 Feb; 28(2):384-8. PubMed ID: 12589392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.